Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 21, 2023

SELL
$463.67 - $597.16 $944,959 - $1.22 Million
-2,038 Reduced 83.01%
417 $206,000
Q2 2022

Aug 15, 2022

SELL
$463.67 - $597.16 $828,114 - $1.07 Million
-1,786 Reduced 66.32%
907 $214,000
Q1 2022

Sep 21, 2023

BUY
$524.57 - $735.42 $1.29 Million - $1.81 Million
2,455 New
2,455 $1.38 Million
Q1 2022

May 16, 2022

BUY
$524.57 - $735.42 $1.41 Million - $1.98 Million
2,693 New
2,693 $1.38 Million
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $204,272 - $257,380
-400 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$454.43 - $535.6 $1.5 Million - $1.77 Million
-3,300 Reduced 89.19%
400 $206,000
Q2 2020

Nov 02, 2020

BUY
$334.87 - $493.06 $1.24 Million - $1.82 Million
3,700 New
3,700 $1.67 Million
Q1 2020

May 15, 2020

SELL
$320.01 - $409.07 $1.16 Million - $1.48 Million
-3,630 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$319.73 - $374.2 $2.13 Million - $2.5 Million
-6,670 Reduced 64.76%
3,630 $1.34 Million
Q3 2019

Nov 13, 2019

BUY
$304.55 - $345.24 $2.38 Million - $2.69 Million
7,800 Added 312.0%
10,300 $3.43 Million
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $3.11 Million - $3.38 Million
-10,822 Reduced 81.23%
2,500 $781,000
Q1 2019

May 15, 2019

BUY
$224.3 - $317.41 $2.19 Million - $3.1 Million
9,769 Added 274.95%
13,322 $4.07 Million
Q4 2018

Feb 14, 2019

BUY
$220.1 - $309.0 $285,029 - $400,155
1,295 Added 57.35%
3,553 $825,000
Q3 2018

Nov 14, 2018

BUY
$289.28 - $326.15 $23,142 - $26,092
80 Added 3.67%
2,258 $707,000
Q2 2018

Aug 14, 2018

BUY
$244.1 - $303.88 $284,132 - $353,716
1,164 Added 114.79%
2,178 $628,000
Q1 2018

May 15, 2018

SELL
$233.97 - $274.11 $2.28 Million - $2.68 Million
-9,766 Reduced 90.59%
1,014 $254,000
Q4 2017

Feb 14, 2018

BUY
$216.94 - $271.3 $1.71 Million - $2.13 Million
7,869 Added 270.32%
10,780 $2.57 Million
Q3 2017

Nov 14, 2017

BUY
$212.27 - $242.28 $617,917 - $705,277
2,911
2,911 $647,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.